KYTX Projected Dividend Yield
Kyverna Therapeutics Inc ( NASDAQ : KYTX )Kyverna Therapeutics is a clinical-stage biotechnology company with the mission of engineering a new class of therapies for autoimmune and inflammatory diseases. Co. platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. 20 YEAR PERFORMANCE RESULTS |
KYTX Dividend History Detail KYTX Dividend News KYTX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |